Recently, Yao et al. [35] reported on broader biological characteristics in initially diagnosed DLBCL patients, revealing that conBMI also shows an enrichment for unfavorable markers such as CD5 expression [38] and MYC gene rearrangement [39]. This evidence concerns the gene CD5 and diffuse large B-cell lymphoma.